Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1966 1
1967 1
1969 1
1970 2
1971 1
1974 1
1975 2
1976 2
1977 2
1978 1
1980 4
1981 1
1983 6
1984 6
1985 4
1986 1
1987 5
1988 9
1989 21
1990 6
1991 10
1992 8
1993 9
1994 12
1995 9
1996 10
1997 7
1998 10
1999 12
2000 16
2001 13
2002 13
2003 12
2004 14
2005 19
2006 11
2007 18
2008 14
2009 16
2010 14
2011 19
2012 11
2013 18
2014 13
2015 17
2016 22
2017 17
2018 19
2019 15
2020 10
2021 17
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

489 results
Results by year
Filters applied: . Clear all
Page 1
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.
Iriguchi S, Yasui Y, Kawai Y, Arima S, Kunitomo M, Sato T, Ueda T, Minagawa A, Mishima Y, Yanagawa N, Baba Y, Miyake Y, Nakayama K, Takiguchi M, Shinohara T, Nakatsura T, Yasukawa M, Kassai Y, Hayashi A, Kaneko S. Iriguchi S, et al. Among authors: yasukawa m. Nat Commun. 2021 Jan 18;12(1):430. doi: 10.1038/s41467-020-20658-3. Nat Commun. 2021. PMID: 33462228 Free PMC article.
Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy.
Minagawa A, Yoshikawa T, Yasukawa M, Hotta A, Kunitomo M, Iriguchi S, Takiguchi M, Kassai Y, Imai E, Yasui Y, Kawai Y, Zhang R, Uemura Y, Miyoshi H, Nakanishi M, Watanabe A, Hayashi A, Kawana K, Fujii T, Nakatsura T, Kaneko S. Minagawa A, et al. Among authors: yasukawa m. Cell Stem Cell. 2018 Dec 6;23(6):850-858.e4. doi: 10.1016/j.stem.2018.10.005. Epub 2018 Nov 15. Cell Stem Cell. 2018. PMID: 30449714 Free article.
CDK1 dependent phosphorylation of hTERT contributes to cancer progression.
Yasukawa M, Ando Y, Yamashita T, Matsuda Y, Shoji S, Morioka MS, Kawaji H, Shiozawa K, Machitani M, Abe T, Yamada S, Kaneko MK, Kato Y, Furuta Y, Kondo T, Shirouzu M, Hayashizaki Y, Kaneko S, Masutomi K. Yasukawa M, et al. Nat Commun. 2020 Mar 25;11(1):1557. doi: 10.1038/s41467-020-15289-7. Nat Commun. 2020. PMID: 32214089 Free PMC article.
[Immunotherapy for hematological neoplasms].
Yasukawa M. Yasukawa M. Rinsho Ketsueki. 2012 Oct;53(10):1759-67. Rinsho Ketsueki. 2012. PMID: 23037749 Review. Japanese. No abstract available.
[Chediak-Higashi syndrome].
Yasukawa M, Ishida Y, Bando S. Yasukawa M, et al. Rinsho Ketsueki. 2008 Apr;49(4):213. Rinsho Ketsueki. 2008. PMID: 18567203 Japanese. No abstract available.
Pyothorax-associated lymphoma.
Yasukawa M, Hamada M, Ohshima K. Yasukawa M, et al. Br J Haematol. 2002 Nov;119(2):293. doi: 10.1046/j.1365-2141.2002.03752.x. Br J Haematol. 2002. PMID: 12406060 No abstract available.
[Primary CD7 deficiency].
Yasukawa M. Yasukawa M. Ryoikibetsu Shokogun Shirizu. 2000;(32):112-3. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11212657 Review. Japanese. No abstract available.
ATF7 mediates TNF-α-induced telomere shortening.
Maekawa T, Liu B, Nakai D, Yoshida K, Nakamura KI, Yasukawa M, Koike M, Takubo K, Chatton B, Ishikawa F, Masutomi K, Ishii S. Maekawa T, et al. Among authors: yasukawa m. Nucleic Acids Res. 2018 May 18;46(9):4487-4504. doi: 10.1093/nar/gky155. Nucleic Acids Res. 2018. PMID: 29490055 Free PMC article.
[Immunotherapy].
Yasukawa M. Yasukawa M. Nihon Rinsho. 2012 Apr;70 Suppl 2:230-5. Nihon Rinsho. 2012. PMID: 23133959 Japanese. No abstract available.
489 results